Recent gene expression profiling of breast cancer has identified specific subtypes with clinical,
biologic, and therapeutic implications. The basal-like group of tumors is characterized by …

Breast cancer is a heterogeneous disease with varied morphological appearances, molecular
features, behavior, and response to therapy. Current routine clinical management of …

Breast cancer is a heterogeneous disease encompassing a variety of entities with distinct
morphological features and clinical behaviors. Although morphology is often associated with …

BACKGROUND. Triple‐negative breast cancer (estrogen receptor‐negative, progesterone
receptor‐negative, and HER2‐negative) is a high risk breast cancer that lacks the benefit of …

Background Immunohistochemical markers are often used to classify breast cancer into
subtypes that are biologically distinct and behave differently. The aim of this study was to …

Purpose The three strongest prognostic determinants in operable breast cancer used in
routine clinical practice are lymph node (LN) stage, primary tumor size, and histologic grade. …

The classification of neuroendocrine neoplasms (NENs) differs between organ systems and
currently causes considerable confusion. A uniform classification framework for NENs at any …

Recent studies on gene molecular profiling using cDNA microarray in a relatively small
series of breast cancer have identified biologically distinct groups with apparent clinical and …

Purpose: Triple-negative (TN; estrogen receptor, progesterone receptor, and HER-2 negative)
cancer and basal-like breast cancer (BLBC) are associated with poor outcome and lack …

Post-translational histone modifications are known to be altered in cancer cells, and loss of
selected histone acetylation and methylation marks has recently been shown to predict …